Strandberg TE (2019) Role of statin therapy in primary prevention of cardiovascular disease in elderly patients. Curr Atheroscler Rep 21(8):28

Article  PubMed  PubMed Central  Google Scholar 

Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, DeMets D, Evans S, Law M, MacMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercock P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R (2016) Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 388(10059):2532–2561

Article  CAS  PubMed  Google Scholar 

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L (2020) 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111–188

Article  PubMed  Google Scholar 

Stam-Slob MC, Visseren FLJ, Wouter Jukema J, van der Graaf Y, Poulter NR, Gupta A (2017) Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Clin Res Cardiol 106(1):58–68

Article  CAS  PubMed  Google Scholar 

Stavropoulos K, Imprialos K, Doumas M, Athyros VG (2018) What is the role of statins in the elderly population? Expert Rev Clin Pharmacol 11(4):329–331

Article  CAS  PubMed  Google Scholar 

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 37(29):2315–2381

Article  PubMed  PubMed Central  Google Scholar 

Cholesterol Treatment Trialists’ Collaboration (2019) Efficacy and safety of statin therapy in older people: A meta-analysis of individual participant data from 28 randomised controlled trials. Lancet 393(10170):407–415

Article  Google Scholar 

Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM et al (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 360(9346):1623–1630

Article  CAS  PubMed  Google Scholar 

Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM (2010) Rosuvastatin for primary prevention in older individuals with high C-reactive protein and low LDL levels: Exploratory analysis of a randomized trial. Ann Intern Med 152(8):488-W174

Article  PubMed  PubMed Central  Google Scholar 

Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S (2017) Primary prevention with statin therapy in the elderly: New meta-analyses from the contemporary JUPITER and HOPE-3 Randomized Trials. Circulation 1

Han BH, Sutin D, Williamson JD, Davis BR, Piller LB, Pervin H et al (2017) Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults. JAMA Intern Med 177(7):955–965

Article  PubMed  PubMed Central  Google Scholar 

Giral P, Neumann A, Weill A, Coste J (2019) Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: A nationwide population-based cohort study in France. Eur Heart J 40(43):3516–3525

Article  PubMed  PubMed Central  Google Scholar 

Kim K, Lee CJ, Shim C-Y, Kim J-S, Kim B-K, Park S et al (2019) Statin and clinical outcomes of primary prevention in individuals aged >75 years: The SCOPE-75 study. Atherosclerosis 284:31–36

Article  CAS  PubMed  Google Scholar 

Jun JE, Cho I-J, Han K, Jeong I-K, Ahn KJ, Chung HY et al (2019) Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study. Atherosclerosis 283:28–34

Article  CAS  PubMed  Google Scholar 

Orkaby AR, Driver JA, Ho Y-L, Lu B, Costa L, Honerlaw J (2020) Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older. JAMA 324(1):68

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lavie G, Hoshen M, Leibowitz M, Benis A, Akriv A, Balicer R, Reges O (2021) Statin therapy for primary prevention in the elderly and its association with new-onset diabetes, cardiovascular events, and all-cause mortality. Am J Med 134(5):643–652

Article  CAS  PubMed  Google Scholar 

Bezin J, Moore N, Mansiaux Y, Steg PG, Pariente A (2019) Real-life benefits of statins for cardiovascular prevention in elderly subjects: A population-based cohort study. Am J Med 132(6):740-748.e7

Article  CAS  PubMed  Google Scholar 

Ramos R, Comas-Cufí M, Martí-Lluch R, Balló E, Ponjoan A, Alves-Cabratosa L (2018) Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: Retrospective cohort study. BMJ k3359

Tobert JA, Newman CB (2016) The nocebo effect in the context of statin intolerance. J Clin Lipidol 10(4):739–747

Article  PubMed  Google Scholar 

Bruckert E, Hayem G, Dejager S, Yau C, Begaud B (2005) Mild to moderate muscular symptoms with highdosage statin therapy in hyperlipidemic patients–the PRIMO study. Cardiovasc Drugs Ther 19:403–414

Article  CAS  PubMed  Google Scholar 

Howard JP, Wood FA, Finegold JA, Nowbar AN, Thompson DM, Arnold AD (2021) Side effect patterns in a crossover trial of statin, placebo, and no treatment. J Am Coll Cardiol 78(12):1210–1222

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ott BR, Daiello LA, Dahabreh IJ, Springate BA, Bixby K, Murali M, Trikalinos TA (2015) Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. J Gen Intern Med 30(3):348–358

Article  PubMed  PubMed Central  Google Scholar 

Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ (2018) Statin use and adverse effects among adults >75 years of age: Insights from the Patient and Provider Assessment of Lipid Management (PALM) Registry. J Am Heart Assoc 7(10):e008546

Article  PubMed  PubMed Central  Google Scholar 

Carlsson AC, Wändell P, Ösby U, Zarrinkoub R, Wettermark B, Ljunggren G (2013) High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health. BMC Public Health 13:670

Article  PubMed  PubMed Central  Google Scholar 

Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register–opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16(7):726–735

Article  PubMed  Google Scholar 

WHO collaborating Centre - ATC/DDD Index [Internet]. [cited 2023 Feb 22]. Available from: https://www.whocc.no/atc_ddd_index/?code=C10AA&showdescription=no

Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A (2009) The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24(11):659–667

Article  PubMed  PubMed Central  Google Scholar 

Wallach Kildemoes H, Vass M, Hendriksen C, Andersen M (2012) Statin utilization according to indication and age: A Danish cohort study on changing prescribing and purchasing behaviour. Health Policy 108(2–3):216–227

Article  PubMed  Google Scholar 

Ruscica M, Macchi C, Pavanello C, Corsini A, Sahebkar A, Sirtori CR (2018) Appropriateness of statin prescription in the elderly. Eur J Intern Med 50:33–40

Article  CAS  PubMed  Google Scholar 

Horodinschi R-N, Stanescu AMA, Bratu OG, Pantea Stoian A, Radavoi DG, Diaconu CC (2019) Treatment with statins in elderly patients. Medicina (Kaunas) 55(11):721

Article  PubMed  Google Scholar 

Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A (2020) Efficacy and safety of lowering LDL cholesterol in older patients: A systematic review and meta-analysis of randomised controlled trials. Lancet 396(10263):1637–1643

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ponce OJ, Larrea-Mantilla L, Hemmingsen B, Serrano V, Rodriguez-Gutierrez R, Spencer-Bonilla G (2019) Lipid-lowering agents in older individuals: A systematic review and meta-analysis of randomized clinical trials. J Clin Endocrinol Metab 104(5):1585–1594